7 Related guidance

Download guidance (PDF)

7.1 NICE has issued the following related technology appraisals:

The clinical effectiveness and cost effectiveness of capecitabine and tegafur uracil for colorectal cancer. NICE technology appraisal no. 61 (2003).
Irinotecan, oxaliplatin and raltitrexed for advanced colorectal cancer (review of NICE technology appraisal no. 33). NICE technology appraisal no. 93 (2005). [Replaced by NICE clinical guideline 131]
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer. NICE technology appraisal no. 100 (2006).
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. NICE technology appraisal guidance 118 (2007).

7.2 NICE has issued guidance on services for people with colorectal cancer:

Improving outcomes in colorectal cancer. NICE cancer service guidance (June 2004).